Citigroup initiated coverage on shares of Basf (OTCMKTS:BASFY – Free Report) in a report published on Wednesday. The brokerage issued a buy rating on the basic materials company’s stock.
A number of other research firms also recently issued reports on BASFY. Berenberg Bank downgraded shares of Basf from a “hold” rating to a “sell” rating in a research report on Tuesday. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Basf in a research report on Wednesday, September 24th. Morgan Stanley upgraded shares of Basf from an “equal weight” rating to an “overweight” rating in a research report on Thursday, July 24th. Finally, Zacks Research upgraded shares of Basf from a “strong sell” rating to a “hold” rating in a research report on Friday, October 10th. Five research analysts have rated the stock with a Buy rating, one has given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold”.
Read Our Latest Stock Analysis on Basf
Basf Trading Up 1.5%
Basf (OTCMKTS:BASFY – Get Free Report) last issued its earnings results on Wednesday, July 30th. The basic materials company reported $0.14 earnings per share for the quarter, missing analysts’ consensus estimates of $0.20 by ($0.06). Basf had a return on equity of 7.17% and a net margin of 0.59%.The business had revenue of $18.10 billion for the quarter, compared to analyst estimates of $15.62 billion. As a group, research analysts expect that Basf will post 0.83 EPS for the current fiscal year.
Basf Company Profile
BASF SE operates as a chemical company worldwide. It operates through six segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care, and Agricultural Solutions. The Chemicals segment provides petrochemicals and intermediates. The Materials segment offers advanced materials and their precursors for applications and systems comprising isocyanates, polyamides, and inorganic basic products, as well as specialties for plastics and plastics processing industries.
Featured Stories
- Five stocks we like better than Basf
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- The Basics of Support and Resistance
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- 5 discounted opportunities for dividend growth investors
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for Basf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basf and related companies with MarketBeat.com's FREE daily email newsletter.